This is the authors' abstract. We don't add key points for this paper.
In this supplement, the authors evaluated existing evidence for the measurement of health-related quality of life (HRQoL) in common bacterial syndromes to determine whether the existing measures are “fit-for-purpose.” Through systematic literature reviews, the authors assessed the use of HRQoL measures in pneumonia, urinary tract infections, skin infections, and intra-abdominal infections [1–4]. Another paper presents a secondary analysis of qualitative research in patients with bloodstream infections reported by source of infection [5]. Another manuscript discusses the process of inter-agency collaboration on patient-centered drug development for infectious diseases [6]. One manuscript describes research methods for developing, interpreting, and analyzing endpoints in clinical trials and provides definitions for terms used in the supplement [7]. The authors' evaluations of current evidence elucidate several challenges and opportunities for measuring HRQoL in infectious diseases studies and clinical practice. For context of use, the supplement authors frame HRQoL evaluation in the context of antimicrobial resistance and registrational trials. However, recent research shows a greater overall burden of poor outcomes in patients with infections susceptible to current drugs [8–10]. Patient-reported symptom and function outcome measures (PROMs) and HRQoL measures are important for all patients regardless of the infecting organisms or susceptibility patterns. The context of use of HRQoL measures can extend beyond endpoints that evaluate the treatment effects of interventions in “registrational” trials. These measures can be useful in clinical practice in making diagnoses, determining which patients benefit from interventions, and following individual patients over time [11]. Including PROMs in routine care has improved survival for cancer patients and may similarly help patients with infections [12].
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Powers et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: